| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 8 buys and 13 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.28M | -119,250 | |
| Other | 755.5K | $4.06M | -29,131 | |
| Dir | 613.6K | $3.30M | - | |
| CFO | 554.5K | $2.98M | -41,884 | |
| COO | 497.8K | $2.68M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2017 | Nimrodi Nir | Svp-corporate Development | Buy | 3,369 | $18.75 | $63,168.75 | +84.2% | |
| Aug 11, 2017 | Lehr Donald P.75 | Chief Legal Officer | Buy | 1,094 | $18.33 | $20,052.91 | +4.0% | |
| Aug 11, 2017 | Perez Jeffrey Thomas71 | SVP, Ip Affairs | Buy | 1,000 | $17.89 | $17,889.90 | +8.7% | |
| Aug 11, 2017 | Kindler Jeffrey B71 | Director | Buy | 5,440 | $18.32 | $99,660.80 | +8.2% | |
| Aug 11, 2017 | Mitchell Dean J45 | Director | Buy | 5,000 | $18.33 | $91,639.50 | +38.2% | |
| May 8, 2017 | Kirk Randal J | 10% Owner | Sell | 160,968 | $3.12 | $501,882.28 | -6.8% | |
| Jan 18, 2017 | Kirk Randal J | 10% Owner | Buy | 2,421,073 | $10.33 | $25,009,684.09 | +88.4% | |
| Dec 29, 2016 | Kirk Randal J | 10% Owner | Sell | 177,020 | $0.48 | $84,375.40 | -3.9% | |
| Dec 13, 2016 | Kirk Randal J | Chief Executive Officer | Buy | 34,606 | $28.90 | $1,000,113.40 | +19.3% | |
| Dec 12, 2016 | Liffman Joel D | SVP, Finance | Buy | 8,500 | $28.62 | $243,264.90 | +5.7% |